VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 56 filers reported holding VINCERX PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $357,921 | -22.3% | 354,377 | 0.0% | 0.01% | -35.0% |
| Q2 2023 | $460,690 | +14.5% | 354,377 | -8.4% | 0.02% | +100.0% |
| Q1 2023 | $402,188 | +2.0% | 386,719 | 0.0% | 0.01% | -41.2% |
| Q4 2022 | $394,453 | -86.4% | 386,719 | -81.6% | 0.02% | -88.4% |
| Q3 2022 | $2,908,000 | +4.6% | 2,107,000 | 0.0% | 0.15% | 0.0% |
| Q2 2022 | $2,781,000 | -67.0% | 2,107,000 | 0.0% | 0.15% | -52.1% |
| Q1 2022 | $8,428,000 | -47.9% | 2,107,000 | +32.8% | 0.30% | -60.1% |
| Q4 2021 | $16,164,000 | -23.8% | 1,586,245 | +20.9% | 0.76% | +28.8% |
| Q3 2021 | $21,222,000 | +206.1% | 1,312,406 | +145.9% | 0.59% | +36.0% |
| Q2 2021 | $6,932,000 | – | 533,668 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,658,199 | $2,189,000 | 0.84% |
| Affinity Asset Advisors, LLC | 1,374,098 | $1,814,000 | 0.76% |
| SABBY MANAGEMENT, LLC | 500,559 | $661,000 | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $1,360,000 | 0.21% |
| Rubric Capital Management LP | 2,107,000 | $2,781,000 | 0.15% |
| Long Focus Capital Management, LLC | 980,000 | $1,294,000 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $508,000 | 0.09% |
| Clearline Capital LP | 452,184 | $597,000 | 0.08% |
| Sio Capital Management, LLC | 102,049 | $135,000 | 0.05% |
| Rock Springs Capital Management LP | 814,194 | $1,075,000 | 0.03% |